Drugs / Dexketoprofen

Trials 19 · a red edge is where a trial was stopped

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 33 trials
Phase 3 NCT06404177 Jul 2023 → Aug 2024 Riadh Boukef Unknown No outcome recorded
Phase 3 NCT01904149 May 2013 → May 2014 Menarini Group Completed No outcome recorded
Phase 3 NCT01902134 Apr 2013 → Feb 2014 Menarini Group Completed No outcome recorded
Phase 411 trials
Phase 4 NCT06060236 Sep 2023 → Sep 2024 disease of bone structure Ankara City Hospital Bilkent Unknown No outcome recorded
Phase 4 NCT05657704 Oct 2022 → Dec 2023 Fundación de Investigación Biomédica - Hospital Universitario de La Princesa Unknown No outcome recorded
Phase 4 NCT04533568 Sep 2020 → Dec 2021 migraine without aura Kecioren Education and Training Hospital Completed No outcome recorded
Phase 4 NCT04609254 Dec 2018 → Apr 2020 Pamukkale University Completed No outcome recorded
Phase 4 NCT04372264 Oct 2018 → May 2020 migraine disorder Pamukkale University Unknown No outcome recorded
Phase 4 NCT03768882 Dec 2017 → Jul 2018 pharyngitis Pamukkale University Completed No outcome recorded
Phase 4 NCT02777970 Apr 2016 → Feb 2017 Menarini Group Completed No outcome recorded
Phase 4 NCT03428503 Dec 2015 → Dec 2016 musculoskeletal system disorder Pamukkale University Completed No outcome recorded
Phase 4 NCT03122314 Aug 2015 → Sep 2016 musculoskeletal system disorder Pamukkale University Completed No outcome recorded
Phase 4 NCT02380001 Jan → Aug 2015 Daniel Chavarría Bolaños Completed No outcome recorded
Phase not applicable5 trials
NCT07386288 Nov 2024 → Apr 2025 Ataturk University Completed No outcome recorded
NCT05176158 Nov 2024 congenital temporomandibular joint ankylosis, impacted teeth, multiple, inflammatory disease Universidad Complutense de Madrid Completed No outcome recorded
NCT04252521 Jul 2019 → Jan 2020 migraine disorder Adiyaman University Research Hospital Completed No outcome recorded
NCT04847024 Jul → Sep 2019 Saint Thomas Hospital, Panama Completed No outcome recorded
NCT05303688 Mar → Oct 2018 neuropathy, painful TC Erciyes University Completed No outcome recorded
Also used as a comparator or background therapy in 35 trials
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 11 trial
Phase 1 NCT05027126 Comparator Feb → Nov 2019 Laboratorios Silanes S.A. de C.V. Completed No outcome recorded
Phase 22 trials
Phase 2 NCT04161690 Comparator Nov 2019 → Nov 2020 KAT General Hospital Unknown No outcome recorded
Phase 2 NCT04178109 Comparator Jan → Nov 2019 KAT General Hospital Completed No outcome recorded
Phase 2/32 trials
Phase 2/3 NCT07057752 Comparator Aug → Oct 2025 peripheral arterial disease Kastamonu University Completed No outcome recorded
Phase 2/3 NCT06222320 Comparator Jan → Oct 2024 Kastamonu University Completed No outcome recorded
Phase 33 trials
Phase 3 NCT05001555 Comparator Nov 2021 → Apr 2023 Laboratorios Silanes S.A. de C.V. Completed No outcome recorded
Phase 3 NCT03585036 Comparator Jul → Sep 2018 Cairo University Unknown No outcome recorded
Phase 3 NCT02602197 Comparator Aug 2013 → Dec 2015 Baskent University Unknown No outcome recorded
Phase 416 trials
Phase 4 NCT06878014 Comparator Mar 2025 → Jun 2026 overdue Medical University of Silesia Recruiting No outcome recorded
Phase 4 NCT06563271 Comparator Dec 2023 → May 2024 Ankara Etlik City Hospital Completed No outcome recorded
Phase 4 NCT06916234 Comparator Jan → Dec 2023 periodontitis ibrahim doğru Completed No outcome recorded
Phase 4 NCT06540599 Comparator Sep → Oct 2022 Gaziosmanpasa Research and Education Hospital Completed No outcome recorded
Phase 4 NCT06932367 Comparator Aug 2021 → Aug 2022 Ali Gur Completed No outcome recorded
Phase not applicable11 trials
NCT07642674 Comparator Jun 2026 → Jan 2027 expected Eskisehir Osmangazi University Recruiting No outcome recorded
NCT07248540 Comparator Jul 2025 → Jan 2026 overdue dysmenorrhea Havva Betül Bacak Recruiting No outcome recorded
NCT06978816 Background Jun 2025 → Jun 2026 overdue urinary system disorder Gao Xiaofeng Recruiting No outcome recorded
NCT06222333 Comparator Nov 2024 → Apr 2025 overdue Kastamonu University Recruiting No outcome recorded
NCT07604376 Background Mar 2024 → Jul 2026 overdue Matild Keresztes Recruiting No outcome recorded

Evidence & citations 15 cited values

Every value below carries the sentence it was read from. 56 sources stand behind the page.

FieldValueCited text
Known as Dexketoprofen “The primary objective of this study is to evaluate the effect of intravenous dexketoprofen administered during the postoperative period on the incidence and severity of rebound...” NCT07642674
52

“All patients will be administered a dose of NSAI intra-muscular or orally ("Dexketoprofen", "Enantyum®") it is part of the normal treatment of these patients to cope with pain.” NCT02527603

“800 mg ibuprofen and 50 mg dexketoprofen in 150 cc normal saline before operation will be given in 30 minutes.” NCT03170713

“Patients in the control group will receive conservative treatment consisting of paracetamol and dexketoprofen.” NCT06222333

“Patients in this group will be treated with painkillers consisting of paracetamol and dexketoprofen.” NCT06222320

“Intravenous infusion of 50 mg dexketoprofen trometamol injection” NCT06978816

“Paracetamol 1g +/- Dexketoprofen trometamol 50mg” NCT04894864

“Patients using oral dexketoprofen for analgesia” NCT06540599

“NSAIDs (ibuprofen, dexketoprofen, pareecoxib)” NCT07604376

Dexketoprofen 25 mg” NCT05657704

DexketoprofenNCT01638962

NCT05176158

NCT04252521

NCT07706036

NCT04533568

NCT04582032

NCT02602197

NCT06060236

NCT05027126

NCT06878014

NCT01902134

NCT06404177

NCT03122314

NCT01904149

NCT02568735

NCT04609254

NCT02929147

NCT05001555

NCT02018601

NCT06916234

NCT02285972

NCT05529290

NCT02373514

NCT07386288

NCT03585036

NCT06563271

NCT06932367

NCT07248540

NCT04161690

NCT03768882

NCT07057752

NCT02380001

NCT04372264

NCT01422291

NCT03428503

NCT04847024

NCT05303688

NCT04178109

NCT01730326

NCT02777970

NCT03865004

NCT05170841

NCT02159547

Known as (s)-ketoprofen ChEMBL registry synonym — accepted as the source's own label CHEMBL75435
Known as arveles “Second Group: dexketoprofen 50 mg ( arveles ampoule -Ufsa- Istanbul) intravenous (IV) was given 70 patients,” NCT04372264
2

“dexketoprofen 50 mg arveles 50 mg ampoule -Menarini- Istanbul) intravenous (IV) was given 70 patients,” NCT04609254

NCT03170726

Known as Dexketoprofen Trometamol “Study patients were randomised into two groups to receive either 50 mg of dexketoprofen trometamol or 1000 mg of paracetamol intravenously by rapid infusion in 150 mL of normal saline.” PMID 24394884 Jan 2014
5

Dexketoprofen trometamol, is one of the most powerful inhibitors of prostaglandin synthesis "in vitro".” NCT02380001

“fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM)” NCT01902134

“Any known allergy or secondary reaction to piroxen or dexketoprofen trometamol.” NCT06404177

Dexketoprofen Trometamol 50 Mg/mL Solution for Injection” NCT06563271

“Drug: Dexketoprofen TrometamolNCT04161690

Known as Dexketoprofen/Vitamin B ClinicalTrials.gov intervention name — accepted as the source's own label NCT05001555
Known as Dexketoprofene ChEMBL registry synonym — accepted as the source's own label CHEMBL75435
Known as Dexketoprofeno ChEMBL registry synonym — accepted as the source's own label CHEMBL75435
Known as DKP “fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM)” NCT01902134
1

“fixed combination of dexketoprofen trometamol (DKP) and tramadol hydrochloride (TRAM)” NCT01904149

Known as Keral ChEMBL registry synonym — accepted as the source's own label CHEMBL75435
Known as KETAVEL “Dexketoprofen (KETAVEL 50 mg/2 ml)” NCT06932367
Known as Metadem (dexketoprofen trometamol) Metadem (dexketoprofen trometamol)NCT04252521
Known as neo ketadex 25 “dexketoprofen 25mg (neo ketadex 25, Marcryl, Egypt)” NCT03585036
Action Inhibit “Dexketoprofen trometamol, is one of the most powerful inhibitors of prostaglandin synthesis "in vitro".” NCT02380001
Modality Small molecule “Dexketoprofen is a new NSAID treating acute postoperative pain.” NCT04161690
Route Intravenous “single intravenous doses of paracetamol (1 g), dexketoprofen (50 mg) and morphine (0.1 mg/kg)” NCT01422291